Dyne Therapeutics (DYN) Current Assets (2019 - 2026)

Dyne Therapeutics (DYN) has 8 years of Current Assets data on file, last reported at $1.0 billion in Q1 2026.

• On a quarterly basis, Current Assets rose 48.08% year-over-year to $1.0 billion in Q1 2026; TTM through Mar 2026 was $1.0 billion, a 48.08% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 70.88% from the prior year.
• Current Assets for Q1 2026 stood at $1.0 billion, down from $1.1 billion in the prior quarter.
• Over the last five years, Current Assets for DYN reached as high as $1.1 billion in Q4 2025 and fell as low as $129.4 million in Q4 2023.
• Historically, Current Assets has averaged $526.1 million across 5 years, with a median of $488.1 million in 2024.
• Across the five-year window, Current Assets tumbled 51.29% in 2023 and surged 409.59% in 2024, its largest moves.
• Year by year, Current Assets stood at $265.6 million in 2022, then tumbled by 51.29% to $129.4 million in 2023, then jumped by 409.59% to $659.3 million in 2024, then surged by 70.88% to $1.1 billion in 2025, then retreated by 9.37% to $1.0 billion in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $1.0 billion in Q1 2026, $1.1 billion in Q4 2025, and $806.3 million in Q3 2025.